Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BDB555557

HLA-DR, DP, DQ Mouse anti-Human, Unlabeled, Clone: TÜ39, BD

Catalog No. BDB555557 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB555557 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB555557 Supplier BD Biosciences Supplier No. 555557
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Reacts with all major histocompatibility Class II HLA-DR, DP and most DQ antigens expressed on B cells, antigen presenting cells and activated T cells. This antibody fixes complement. This antibody is routinely tested by flow cytometric analysis. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.

TRUSTED_SUSTAINABILITY

Specifications

Antigen HLA-DR, DP, DQ
Applications Flow Cytometry
Classification Monoclonal
Clone TÜ39
Concentration 0.5mg/mL
Conjugate Unconjugated
Description Tü39
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Host Species Mouse
Purification Method Affinity Purified
Quantity 0.1 mg
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C
Isotype IgG2a κ
Show More Show Less

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.